Atlas Trials

Relative Bioavailability Study of GSK1265744 Formulations

Clinical trial NCT01648257 · COMPLETED

Trial details

NCT number
NCT01648257
Sponsor
ViiV Healthcare
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Infections, Human Immunodeficiency Virus and Hepatitis
Start date
2012-08-01
Primary completion
2012-11-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.